Last Updated by Anonymous | Update This Page Flag this page Delete This Page

rating: 0+x

"The company’s key strategic business objectives include global Launch of KALYDECO in Cystic Fibrosis and expansion of its KALYDE" has a significant impact, so an analyst should put more weight into it. This statements will have a short-term positive impact on this entity, which adds to its value.